Table 1 Patient characteristics
Cycle interval | < 120 days | ≥ 120 days |
|---|---|---|
N | 68 | 17 |
Age (years) | 40.50 ± 4.45 | 41.59 ± 3.16 |
BMI (kg/m2) | 23.73 ± 3.9 | 23.00 ± 4.07 |
FSH (mIU/mL) | 19.6 ± 17.9 | 16.7 ± 21.4 |
AMH (ng/mL) | 0.42 ± 0.41 | 0.54 ± 0.40 |
Gonadotropin dosage/IVF cycle | 6720 ± 2403 | 6209 ± 2646 |
Oocyte yield/IVF cycle | 2.87 ± 3.03 | 3.49 ± 3.23 |
Race (n/%) | ||
Caucasian | 49 (72%) | 10 (65%) |
African | 10 (15%) | 3 (12%) |
Asian | 9 (13%) | 4 (24%) |
Diagnosis (n/%) | ||
Male factor | 13 (18.1%) | 4 (23.5%) |
Endometriosis | 4 (5.6%) | 1 (5.9%) |
PCO | 0 (0.0%) | 0 (0.0%) |
DOR | 55 (76.4%) | 11 (64.7%) |
Tubal | 12 (16.7%) | 2 (11.8%) |
Uterine | 5 (6.9%) | 1 (5.9%) |